00 Enrolled HB 240
01 Relating to prescription prices available to consumers; relating to penalties for certain
02 pharmacy or pharmacist violations; relating to the registration and duties of pharmacy benefits
03 managers; relating to procedures, guidelines, and enforcement mechanisms for pharmacy
04 audits; relating to the cost of multi-source generic drugs and insurance reimbursement
05 procedures; relating to the duties of the director of the division of insurance; and providing for
06 an effective date.
08 * Section 1. AS 08.80.297 is amended by adding a new subsection to read:
09 (b) No contract or agreement may prohibit a pharmacy, pharmacist, or
10 pharmacy benefits manager from informing a patient of a less costly alternative for a
11 prescription drug or medical device or supply, which may include the amount the
12 patient would pay without the use of a health care plan.
13 * Sec. 2. AS 08.80.297 is amended by adding new subsections to read:
01 (c) A pharmacist or person acting at the direction of a pharmacist shall notify
02 the patient if a known less costly alternative for a prescription drug or medical device
03 or supply is available, which may include the amount the patient would pay without
04 the use of a health care plan.
05 (d) In this section,
06 (1) "health care plan" means a policy, contract, benefit, or agreement
07 that provides, delivers, arranges for, pays for, or reimburses any of the costs of health
08 care services under
09 (A) a health care insurance plan as defined under
10 AS 21.54.500;
11 (B) a governmental or employee welfare benefit plan under 29
12 U.S.C. 1001 - 1191 (Employee Retirement Income Security Act of 1974);
13 (C) a plan offered under AS 39.30.090 or 39.30.091;
14 (D) a federal governmental plan as defined under
15 AS 21.54.500;
16 (E) the Medicaid or Medicare program; or
17 (F) a self-insured employer benefit plan;
18 (2) "pharmacy benefits manager" has the meaning given in
19 AS 21.27.955.
20 * Sec. 3. AS 08.80.460(a) is amended to read:
21 (a) Except for a violation of AS 08.80.297, a [A] person who violates a
22 provision of this chapter is guilty of a class B misdemeanor.
23 * Sec. 4. AS 08.80.460(b) is amended to read:
24 (b) A person who violates the provisions of AS 08.80.295 or 08.80.297 may
25 be punished [IS PUNISHABLE] by a civil fine in an amount established by the board
26 in a schedule or schedules establishing the amount of civil fine for a particular
27 violation. The schedule or schedules shall be adopted by the board by regulation. Any
28 civil fine imposed under this section may be appealed in the manner provided for
29 appeals in AS 44.62 (Administrative Procedure Act).
30 * Sec. 5. AS 21.27 is amended by adding new sections to read:
31 Article 10. Pharmacy Benefits Managers.
01 Sec. 21.27.901. Registration of pharmacy benefits managers; scope of
02 business practice. (a) A person may not conduct business in the state as a pharmacy
03 benefits manager unless the person is registered with the director as a third-party
04 administrator under AS 21.27.630.
05 (b) A pharmacy benefits manager registered under AS 21.27.630 may
06 (1) contract with an insurer to administer or manage pharmacy benefits
07 provided by an insurer for a covered person, including claims processing services for
08 and audits of payments for prescription drugs and medical devices and supplies;
09 (2) contract with network pharmacies;
10 (3) set the cost of multi-source generic drugs under AS 21.27.945; and
11 (4) adjudicate appeals related to multi-source generic drug
13 Sec. 21.27.905. Renewal of registration. (a) A pharmacy benefits manager
14 shall biennially renew a registration with the director.
15 (b) To renew a registration under this section, a pharmacy benefits manager
16 shall pay a renewal fee established by the director. The director shall set the amount of
17 the renewal fee to allow the renewal and oversight activities of the division to be self-
19 Sec. 21.27.910. Pharmacy audit procedural requirements. (a) When a
20 pharmacy benefits manager conducts an audit of the records of a pharmacy, the period
21 covered by the audit of a claim may not exceed two years from the date that the claim
22 was submitted to or adjudicated by the pharmacy benefits manager, whichever is
23 earlier. Except as required under AS 21.36.495, a claim submitted to or adjudicated by
24 a pharmacy benefits manager does not accrue interest during the audit period.
25 (b) A pharmacy benefits manager conducting an on-site audit shall give the
26 pharmacy written notice of at least 10 business days before conducting an initial audit.
27 (c) A pharmacy benefits manager may not conduct
28 (1) an audit during the first seven calendar days of any month unless
29 agreed to by the pharmacy;
30 (2) more than one on-site audit of a pharmacy within a 12-month
31 period; or
01 (3) on-site audits of more than 250 separate prescriptions at one
02 pharmacy within a 12-month period unless fraud by the pharmacy or an employee of
03 the pharmacy is alleged.
04 (d) If an audit involves clinical or professional judgment, the individual
05 conducting the audit must
06 (1) be a pharmacist who is licensed and in good standing under
07 AS 08.80; or
08 (2) conduct the audit in consultation with a pharmacist who is licensed
09 and in good standing under AS 08.80.
10 (e) A pharmacy, in responding to an audit, may use
11 (1) verifiable statements or records, including medication
12 administration records of a nursing home, assisted living facility, hospital, physician,
13 or other authorized practitioner, to validate the pharmacy record;
14 (2) a legal prescription to validate claims in connection with
15 prescriptions, refills, or changes in prescriptions, including medication administration
16 records, prescriptions transmitted by facsimile, electronic prescriptions, or
17 documented telephone calls from the prescriber or the prescriber's agent.
18 (f) A pharmacy benefits manager shall audit each pharmacy under the same
19 standards and parameters as other similarly situated pharmacies in a network
20 pharmacy contract in this state.
21 Sec. 21.27.915. Overpayment or underpayment. (a) When a pharmacy
22 benefits manager conducts an audit of a pharmacy, the pharmacy benefits manager
23 shall base a finding of overpayment or underpayment by the pharmacy on the actual
24 overpayment or underpayment and not on a projection based on the number of patients
25 served having a similar diagnosis or on the number of similar orders or refills for
26 similar drugs, except as provided in (b) of this section.
27 (b) A pharmacy benefits manager may resolve a finding of overpayment or
28 underpayment by entering into a settlement agreement with the pharmacy. The
29 settlement agreement
30 (1) must comply with the requirements of AS 21.36.125; and
31 (2) may be based on a statistically justifiable projection method.
01 (c) A pharmacy benefits manager may not include the dispensing fee amount
02 in a finding of an overpayment unless
03 (1) a prescription was not actually dispensed;
04 (2) the prescriber denied authorization;
05 (3) the prescription dispensed was a medication error by the pharmacy;
07 (4) the identified overpayment is solely based on an extra dispensing
09 Sec. 21.27.920. Recoupment. (a) When a pharmacy benefits manager
10 conducts an audit of a pharmacy, the pharmacy benefits manager shall base the
11 recoupment of overpayments on the actual overpayment of the claim, except as
12 provided in AS 21.27.915(b).
13 (b) A pharmacy benefits manager conducting an audit of a pharmacy may not
14 (1) use extrapolation in calculating recoupments or penalties for audits,
15 unless required by state or federal contracts;
16 (2) assess a charge-back, recoupment, or other penalty against a
17 pharmacy solely because a prescription is mailed or delivered at the request of a
18 patient; or
19 (3) receive payment
20 (A) based on a percentage of the amount recovered; or
21 (B) for errors that have no actual financial harm to the patient
22 or medical plan.
23 Sec. 21.27.925. Pharmacy audit reports. (a) A pharmacy benefits manager
24 shall deliver a preliminary audit report to the pharmacy audited within 60 days after
25 the conclusion of the audit.
26 (b) A pharmacy benefits manager shall allow the pharmacy at least 30 days
27 following receipt of the preliminary audit report to provide documentation to the
28 pharmacy benefits manager to address a discrepancy found in the audit. A pharmacy
29 benefits manager may grant a reasonable extension upon request by the pharmacy.
30 (c) A pharmacy benefits manager shall deliver a final audit report to the
31 pharmacy within 120 days after receipt of the preliminary audit report, settlement
01 agreement, or final appeal, whichever is latest.
02 Sec. 21.27.930. Pharmacy audit appeal; future repayment. (a) A pharmacy
03 benefits manager conducting an audit shall establish a written appeals process.
04 (b) Recoupment of disputed funds or repayment of funds to the pharmacy
05 benefits manager by the pharmacy, if permitted by contract, shall occur, to the extent
06 demonstrated or documented in the pharmacy audit findings, after final internal
07 disposition of the audit, including the appeals process. If the identified discrepancy for
08 an individual audit exceeds $15,000, future payments to the pharmacy may be
09 withheld pending finalization of the audit.
10 (c) A pharmacy benefits manager may not assess against a pharmacy a charge-
11 back, recoupment, or other penalty until the pharmacy benefits manager's appeals
12 process has been exhausted and the final report or settlement agreement issued.
13 Sec. 21.27.935. Fraudulent activity. When a pharmacy benefits manager
14 conducts an audit of a pharmacy, the pharmacy benefits manager may not consider
15 unintentional clerical or record-keeping errors, including typographical errors, writer's
16 errors, or computer errors regarding a required document or record, to be fraudulent
17 activity. In this section, "fraudulent activity" means an intentional act of theft,
18 deception, misrepresentation, or concealment committed by the pharmacy.
19 Sec. 21.27.940. Pharmacy audits; restrictions. The requirements of
20 AS 21.27.901 - 21.27.955 do not apply to an audit
21 (1) in which suspected fraudulent activity or other intentional or wilful
22 misrepresentation is evidenced by a physical review, a review of claims data, a
23 statement, or another investigative method; or
24 (2) of claims paid for under the medical assistance program under
25 AS 47.07.
26 Sec. 21.27.945. Drug pricing list; procedural requirements. (a) A pharmacy
27 benefits manager shall
28 (1) make available to each network pharmacy at the beginning of the
29 term of the network pharmacy's contract, and upon renewal of the contract, the
30 methodology and sources used to determine the drug pricing list;
31 (2) provide a telephone number at which a network pharmacy may
01 contact an employee of a pharmacy benefits manager to discuss the pharmacy's
03 (3) provide a process for a network pharmacy to have ready access to
04 the list specific to that pharmacy;
05 (4) review and update applicable list information at least once every
06 seven business days to reflect modification of list pricing;
07 (5) update list prices within one business day after a significant price
08 update or modification provided by the pharmacy benefits manager's national drug
09 database provider; and
10 (6) ensure that dispensing fees are not included in the calculation of the
11 list pricing.
12 (b) When establishing a list, the pharmacy benefits manager shall use
13 (1) the most up-to-date pricing data to calculate reimbursement to a
14 network pharmacy for drugs subject to list prices;
15 (2) multi-source generic drugs that are sold or marketed in the state
16 during the list period.
17 Sec. 21.27.950. Multi-source generic drug appeal. (a) A pharmacy benefits
18 manager shall establish a process by which a network pharmacy, or a network
19 pharmacy's contracting agent, may appeal the reimbursement for a multi-source
20 generic drug. A pharmacy benefits manager shall resolve an appeal from a network
21 pharmacy within 10 calendar days after the network pharmacy or the contracting agent
22 submits the appeal.
23 (b) A network pharmacy, or a network pharmacy's contracting agent, may
24 appeal a reimbursement from a pharmacy benefits manager for a multi-source generic
25 drug if the reimbursement for the drug is less than the amount that the network
26 pharmacy can purchase from two or more of its contracted suppliers.
27 (c) A pharmacy benefits manager may grant a network pharmacy's appeal if
28 an equivalent multi-source generic drug is not available at a price at or below the
29 pharmacy benefits manager's list price for purchase from national or regional
30 wholesalers who operate in the state. If an appeal is granted, the pharmacy benefits
31 manager shall adjust the reimbursement of the network pharmacy to equal the network
01 pharmacy acquisition cost for each paid claim included in the appeal.
02 (d) If the pharmacy benefits manager denies a network pharmacy's appeal, the
03 pharmacy benefits manager shall provide the network pharmacy with the
04 (1) reason for the denial;
05 (2) national drug code of an equivalent multi-source generic drug that
06 has been purchased by another network pharmacy located in the state at a price that is
07 equal to or less than the pharmacy benefits manager's list price within seven days after
08 the network pharmacy appeals the claim; and
09 (3) name of a pharmaceutical wholesaler who operates in the state in
10 which the drug may be acquired by the challenging network pharmacy.
11 (e) A network pharmacy may request a hearing under AS 21.06.170 -
12 21.06.240 for an adverse decision from a pharmacy benefits manager within 30
13 calendar days after receiving the decision. The parties may present all relevant
14 information to the director for the director's review.
15 (f) The director shall enter an order that
16 (1) grants the network pharmacy's appeal and directs the pharmacy
17 benefits manager to make an adjustment to the disputed claim;
18 (2) denies the network pharmacy's appeal; or
19 (3) directs other actions considered fair and equitable.
20 Sec. 21.27.955. Definitions. In AS 21.27.901 - 21.27.955,
21 (1) "audit" means an official examination and verification of accounts
22 and records;
23 (2) "claim" means a request from a pharmacy or pharmacist to be
24 reimbursed for the cost of filling or refilling a prescription for a drug or for providing
25 a medical supply or device;
26 (3) "extrapolation" means the practice of inferring a frequency or
27 dollar amount of overpayments, underpayments, invalid claims, or other errors on any
28 portion of claims submitted, based on the frequency or dollar amount of
29 overpayments, underpayments, invalid claims, or other errors actually measured in a
30 sample of claims;
31 (4) "list" means the list of multi-source generic drugs for which a
01 predetermined reimbursement amount has been established such as a maximum
02 allowable cost or maximum allowable cost list or any other list of prices used by a
03 pharmacy benefits manager;
04 (5) "multi-source generic drug" means any covered outpatient
05 prescription drug that the United States Food and Drug Administration has determined
06 is pharmaceutically equivalent or bioequivalent to the originator or name brand drug
07 and for which there are at least two drug products that are rated as therapeutically
08 equivalent under the United States Food and Drug Administration's most recent
09 publication of "Approved Drug Products with Therapeutic Equivalence Evaluations";
10 (6) "network pharmacy" means a pharmacy that provides covered
11 health care services or supplies to an insured or a member under a contract with a
12 network plan to act as a participating provider;
13 (7) "pharmacy" has the meaning given in AS 08.80.480;
14 (8) "pharmacy acquisition cost" means the amount that a
15 pharmaceutical wholesaler or distributor charges for a pharmaceutical product as listed
16 on the pharmacy's invoice;
17 (9) "pharmacy benefits manager" means a person that contracts with a
18 pharmacy on behalf of an insurer to process claims or pay pharmacies for prescription
19 drugs or medical devices and supplies or provide network management for
21 (10) "recoupment" means the amount that a pharmacy must remit to a
22 pharmacy benefits manager when the pharmacy benefits manager has determined that
23 an overpayment to the pharmacy has occurred.
24 * Sec. 6. The uncodified law of the State of Alaska is amended by adding a new section to
26 APPLICABILITY. (a) AS 21.27.901 - 21.27.955, enacted by sec. 5 of this Act, apply
27 to audits of pharmacies conducted by pharmacy benefits managers and contracts entered into
28 or renewed on or after the effective date of sec. 5 of this Act.
29 (b) AS 08.80.297(b), enacted by sec. 1 of this Act, applies to contracts entered into or
30 renewed on or after the effective date of sec. 1 of this Act.
31 (c) In this section, "pharmacy" and "pharmacy benefits manager" have the meanings
01 given in AS 21.27.955, enacted by sec. 5 of this Act.
02 * Sec. 7. The uncodified law of the State of Alaska is amended by adding a new section to
04 TRANSITIONAL PROVISIONS: REGULATIONS. The division of insurance may
05 adopt regulations necessary to implement the changes made by this Act. The regulations take
06 effect under AS 44.62 (Administrative Procedure Act), but not before the effective date of the
07 law implemented by the regulation.
08 * Sec. 8. The uncodified law of the State of Alaska is amended by adding a new section to
10 REVISOR'S INSTRUCTIONS. The revisor of statutes is requested to renumber
11 AS 21.27.900 as AS 21.27.990. The revisor of statutes is requested to change "AS 21.27.900"
12 to "AS 21.27.990" in AS 21.36.475(c)(2) and (4) and AS 21.97.900(27).
13 * Sec. 9. Sections 1, 3, 6(b), and 7 of this Act take effect immediately under
14 AS 01.10.070(c).
15 * Sec. 10. Except as provided in sec. 9 of this Act, this Act takes effect July 1, 2019.